Patents by Inventor Nader Z. Pourhassen

Nader Z. Pourhassen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200385475
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal antibody therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Application
    Filed: January 8, 2020
    Publication date: December 10, 2020
    Inventors: Robert T. Schooley, Nader Z. Pourhassen
  • Patent number: 10562969
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal anti-body therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: February 18, 2020
    Assignee: Cytodyn Inc.
    Inventors: Robert T. Schooley, Nader Z. Pourhassen
  • Publication number: 20170335002
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal anti-body therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Application
    Filed: August 20, 2015
    Publication date: November 23, 2017
    Applicant: CYTODYN INC.
    Inventors: Robert T. Schooley, Nader Z. Pourhassen